Atlas Trials

Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT

Clinical trial NCT00230477 · COMPLETED

Trial details

NCT number
NCT00230477
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B
Start date
2003-04-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.